ClinicalTrials.Veeva

Menu

The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care (HEMOCARD)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Cardiogenic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT05752383
PI2022_843_0132

Details and patient eligibility

About

Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, temporary mechanical circulatory support has become more important in cardiogenic shock. The monitoring of catecholamines is also performed with a global score: the vaso-inotropic score. The purpose of our study is to consider using these new data and techniques to create a cohort of cardiogenic shock within our critical care unit.

This observational study is based on clinical, biological, and hemodynamic data recorded during the ICU stay of patients for cardiogenic shock.

The primary endpoint is the relationship between the hemodynamic evolution of cardiogenic shock and in-hospital mortality.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients hospitalized in ICU for cardiogenic shock
  • Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria

Exclusion criteria

  • Patient with cardiogenic shock in the context of septic shock and hemorrhagic shock

Trial contacts and locations

1

Loading...

Central trial contact

Christophe Beyls, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems